Lineage Cell Therapeutics (NYSEAM:LCTX) Earnings Call Presentation

From promise to people. Our mission is to pioneer a new branch of medicine based on the directed differentiation and transplant of allogeneic cells to patients CORPORATE OVERVIEW MARCH 24, 2026 NYSE AMERICAN: LCTX lineagecell.com Forward-Looking Statements Cell manufacturing and transplant technology 7 Cell types in development Highly Differentiated Allogeneic product candidates 2 Active clinical trials >200 Cell types as potential targets This presentation is for informational purposes only and is not an o ...